Ermont, France

Thierry Garnier

USPTO Granted Patents = 2 

 


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Paris, FR (2011)
  • Ermont, FR (2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Thierry Garnier: Pioneering Advances in Vaccination Diagnostics

Introduction

Thierry Garnier is a notable inventor based in Ermont, France, recognized for his contributions to the field of immunization and diagnostics. With a focus on biotechnology, Garnier has garnered attention for his innovative approaches and the development of novel vaccines that address critical health challenges.

Latest Patents

Garnier holds two significant patents that reflect his expertise in identifying nucleotide and peptide sequences essential for differentiating between infections resulting from BCG vaccination and actual infections. His first patent addresses the isolation of these sequences and presents methods for detecting them, as well as the antibodies generated by products expressing these sequences. The invention aims to improve diagnostic capabilities associated with BCG vaccination and related infections. The second patent identifies a nucleotide sequence that helps distinguish infections resulting from various strains from those resulting from BCG, further enhancing diagnostic accuracy. Both inventions contribute to novel vaccine developments aimed at improving public health outcomes.

Career Highlights

Thierry Garnier works with the prestigious Institut Pasteur, renowned for its dedication to medical research and innovation. His work is pivotal in advancing the field of vaccines and diagnostics, which are crucial for combating infectious diseases. The depth of his research has positioned him among leading scientists in his domain, showcasing his commitment to innovative healthcare solutions.

Collaborations

Throughout his career, Garnier has collaborated with other prominent researchers, including Stewart T. Cole and Stéphen Gordon. These collaborations have allowed for a fusion of ideas and expertise, further propelling research initiatives within the field of immunization and vaccine development.

Conclusion

Thierry Garnier's innovative work, particularly in vaccine diagnostics and development, exemplifies the intersection of science and public health. With two critical patents to his name and collaborations with notable researchers, Garnier continues to make significant contributions to medical science, enhancing our understanding and management of infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…